4,4,5,5-Tetramethyl-2-(2-((4-methylbenzyl)oxy)phenyl)-1,3,2-dioxaborolane, 98%, 10g

2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

ACRIVASTINE, 95%, 250mg

4-[[(HEXYLAMINO)CARBONYL]AMINO]-N-[4-[2-[[(2S)-2-HYDROXY-3-(4-HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]-BENZENESULFONAMIDE, 95%, 50mg

tert-Butyl (3R)-3-{4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl}piperidine-1-carboxylate, 98%, 5g

3-(Benzyloxy)-2-methoxybenzaldehyde, 98%, 1g

Monocrotaline, min. 99%, 500 mg, glass packaging

3-Acetoxy-2-phenylpropanoic acid, 95.0%, 5g

3,5-Dimethyl-1-phenyl-1H-pyrazole-4-sulfonylchloride, 95.0%, 100mg

2,5-Dimethylterephthalic Acid>97.0%(GC)(T)25g

3-Bromo-5-methyl-4-nitropyridine, 95.0%, 500mg

BOC-DAP(Fmoc)-OH, 95.0%, 10g

4-(2,4-Dichlorobenzoyl)-2-methylpyridine, 97.0%, 1g